Peter M Carlson

7PUBLICATIONS
38CO-AUTHORS
Radiation therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2026
In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.

|Dec 25, 2025
Immune-mediated Engagement of T Regulatory Cells with Tumor Cells Results in Trogocytosis and Tumor Cell Killing.

Amy K Erbe, Arika S Feils, Anqi Gao

|Jan 13, 2023
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.

Peter M Carlson, Ravi B Patel, Jen Birstler

|Jul 15, 2021
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.

Ravi B Patel, Reinier Hernandez, Peter Carlson

|Jul 15, 2021
Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.

Peter M Carlson, Manasi Mohan, Ravi B Patel

|Jun 26, 2021
Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice.

Alexander A Pieper, Alexander L Rakhmilevich, Daniel V Spiegelman

Pageof 2

Frequent Collaborators

6 joint publications

Ravi B Patel

5 joint publications

Paul M Sondel

3 joint publications

Zachary S Morris

2 joint publications

Reinier Hernandez